Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126604872 | 12660487 | 2 | F | 20160819 | 20160817 | 20160825 | EXP | NL-MYLANLABS-2016M1034350 | MYLAN | TROELSTRA NAM, RUTTEN AMF, DUISENBERG-VAN ESSENBERG M. MIXED DRUG INTOXICATION WITH VALPROIC ACID, QUETIAPINE AND OXAZEPAM COMBINED WITH ALCOHOL. CRITICAL ANALYSIS OF THE TREATMENT RESULTS AFTER RAPID INTERVENTION. [DUTCH]. PHARM-WEEKBL 2015;150(50):271-274. | 0.00 | Y | 0.00000 | 20160825 | OT | NL | NL |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126604872 | 12660487 | 1 | SS | OXAZEPAM. | OXAZEPAM | 1 | Oral | 1.1G | 0 | ||||||||||
| 126604872 | 12660487 | 2 | PS | QUETIAPINE. | QUETIAPINE | 1 | Oral | 13G | 90323 | TABLET | |||||||||
| 126604872 | 12660487 | 3 | SS | VALPROIC ACID. | VALPROIC ACID | 1 | Oral | 45G | 0 | MODIFIED-RELEASE TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126604872 | 12660487 | 1 | Product used for unknown indication |
| 126604872 | 12660487 | 2 | Product used for unknown indication |
| 126604872 | 12660487 | 3 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126604872 | 12660487 | OT |
| 126604872 | 12660487 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126604872 | 12660487 | Blood creatine phosphokinase increased | |
| 126604872 | 12660487 | Coma | |
| 126604872 | 12660487 | Dyspnoea | |
| 126604872 | 12660487 | Electrocardiogram QT prolonged | |
| 126604872 | 12660487 | Haemodynamic instability | |
| 126604872 | 12660487 | Hyperammonaemia | |
| 126604872 | 12660487 | Intentional product misuse | |
| 126604872 | 12660487 | Liver disorder | |
| 126604872 | 12660487 | Metabolic encephalopathy | |
| 126604872 | 12660487 | Overdose | |
| 126604872 | 12660487 | Toxicity to various agents |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |